Cothera Bioscience
At a glance
- Status
- Operational
- Headquarters
- Hangzhou, China
- Open positions
- None listed
- Dealroom signal
- 0.0/100
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Jan 2021 | $30M | $120M | Tsing Capital · Langsheng Investment · Sherpa Venture Partners · Harbinger Ventures | — |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A7 investors entered at this stage
- TCTsing Capital
- LILangsheng Investment
Sherpa Venture Partners- HVHarbinger Ventures
- NINew World (China) Investment
- CICMB International
- KFKunlun Fund
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cothera Bioscience on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cothera Bioscience’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.